Real-world experience managing blinatumomab toxicities in adults with relapsed/refractory acute lymphoblastic leukemia:

PurposeThe purpose of this study was to determine the effect of blinatumomab toxicities on drug therapy modifications in an intended 28-day course of blinatumomab therapy.MethodsPatients with acute...